24 July 2023
24 July 2023
The Clinical Trials Arena team also review assets in oncology and musculoskeletal disorder indications.
Patients treated with the combined therapy in the trial showed typical adverse events.
RWJ Barnabas Health Medical active job postings continue to increase over the last 30 days.
Janssen has plans to discontinue the CD388 influenza programme as part of pipeline prioritisation, but Cidara plans to continue development.
The drug is marketed as WAKIX and has been used by adult patients with narcolepsy since its FDA approval and commercial availability in 2019.
More detailed timelines will depend on the data readout from a Phase II registration-directed study in the US in Q3 2023.
A significant 21% reduction in MACE or death in the pitavastatin group, compared to the placebo group, was observed in the trial.
Overall survival is the primary endpoint of the trial, and the one-year survival rate and progression free survival are the secondary endpoints.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
